Single agent nanoparticle for radiotherapy and radio-photothermal therapy in anaplastic thyroid cancer.

[1]  H. Dai,et al.  In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. , 2020, Nature nanotechnology.

[2]  J. Copland,et al.  Pazopanib Enhances Paclitaxel-Induced Mitotic Catastrophe in Anaplastic Thyroid Cancer , 2013, Science Translational Medicine.

[3]  A. Jemal,et al.  Cancer statistics, 2013 , 2013, CA: a cancer journal for clinicians.

[4]  C. Dodge,et al.  Targeting STAT3 inhibits growth and enhances radiosensitivity in head and neck squamous cell carcinoma. , 2012, Oral Oncology.

[5]  C. Xiong,et al.  Effective photothermal chemotherapy using doxorubicin-loaded gold nanospheres that target EphB4 receptors in tumors. , 2012, Cancer research.

[6]  Qian Huang,et al.  Copper sulfide nanoparticles as a new class of photoacoustic contrast agent for deep tissue imaging at 1064 nm. , 2012, ACS nano.

[7]  N. Lee,et al.  Concurrent doxorubicin and radiotherapy for anaplastic thyroid cancer: a critical re-evaluation including uniform pathologic review. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  M. Melancon,et al.  Cancer theranostics with near-infrared light-activatable multimodal nanoparticles. , 2011, Accounts of chemical research.

[9]  Mei Zhao,et al.  Assembly and Initial Characterization of a Panel of 85 Genomically Validated Cell Lines from Diverse Head and Neck Tumor Sites , 2011, Clinical Cancer Research.

[10]  C. Anderson,et al.  Monoclonal antibodies for copper-64 PET dosimetry and radioimmunotherapy , 2011, Cancer biology & therapy.

[11]  Y. Ni,et al.  Small-Animal PET of Tumor Damage Induced by Photothermal Ablation with 64Cu-Bis-DOTA-Hypericin , 2011, The Journal of Nuclear Medicine.

[12]  R. Stafford,et al.  Theranostics With Multifunctional Magnetic Gold Nanoshells: Photothermal Therapy and T2* Magnetic Resonance Imaging , 2011, Investigative radiology.

[13]  Ge Zhou,et al.  Targeted Therapy of VEGFR2 and EGFR Significantly Inhibits Growth of Anaplastic Thyroid Cancer in an Orthotopic Murine Model , 2011, Clinical Cancer Research.

[14]  Dong Liang,et al.  A chelator-free multifunctional [64Cu]CuS nanoparticle platform for simultaneous micro-PET/CT imaging and photothermal ablation therapy. , 2010, Journal of the American Chemical Society.

[15]  J. Copland,et al.  Anaplastic thyroid carcinoma: pathogenesis and emerging therapies. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

[16]  R. Shukla,et al.  Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-198AuNP nanoconstruct in prostate tumor-bearing mice. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[17]  Gloria C. Li,et al.  The effect of mild temperature hyperthermia on tumour hypoxia and blood perfusion: relevance for radiotherapy, vascular targeting and imaging , 2010, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

[18]  G. Pizzolo,et al.  Plasmacytoid dendritic cell leukemia: a rapidly evolving disease presenting with skin lesions sensitive to radiotherapy plus hyperthermia. , 2009, The oncologist.

[19]  A. Garden,et al.  Anaplastic thyroid cancer: Clinical outcomes with conformal radiotherapy , 2009, Head & neck.

[20]  Hao Hong,et al.  Molecular imaging and therapy of cancer with radiolabeled nanoparticles. , 2009, Nano today.

[21]  C. Anderson,et al.  Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research. , 2009, Cancer biotherapy & radiopharmaceuticals.

[22]  Amy Y. Chen,et al.  Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005 , 2009, Cancer.

[23]  C. Anderson,et al.  Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET). , 2009, Accounts of chemical research.

[24]  Mark E. Davis,et al.  Pharmacokinetics and tumor dynamics of the nanoparticle IT-101 from PET imaging and tumor histological measurements , 2009, Proceedings of the National Academy of Sciences.

[25]  Wei Lu,et al.  Targeted Photothermal Ablation of Murine Melanomas with Melanocyte-Stimulating Hormone Analog–Conjugated Hollow Gold Nanospheres , 2009, Clinical Cancer Research.

[26]  Min-Hua Chen,et al.  Comparative dosimetric evaluation of nanotargeted (188)Re-(DXR)-liposome for internal radiotherapy. , 2008, Cancer biotherapy & radiopharmaceuticals.

[27]  Wei Lu,et al.  In vitro and in vivo targeting of hollow gold nanoshells directed at epidermal growth factor receptor for photothermal ablation therapy , 2008, Molecular Cancer Therapeutics.

[28]  Robert Sinclair,et al.  Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice. , 2008, Small.

[29]  Eric D. Pressly,et al.  Structural effects on the biodistribution and positron emission tomography (PET) imaging of well-defined (64)Cu-labeled nanoparticles comprised of amphiphilic block graft copolymers. , 2007, Biomacromolecules.

[30]  Sanjiv S Gambhir,et al.  microPET-Based Biodistribution of Quantum Dots in Living Mice , 2007, Journal of Nuclear Medicine.

[31]  J. Overgaard,et al.  Hyperthermia: a potent enhancer of radiotherapy. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[32]  Kai Qi,et al.  64Cu-labeled folate-conjugated shell cross-linked nanoparticles for tumor imaging and radiotherapy: synthesis, radiolabeling, and biologic evaluation. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[33]  Michael G Stabin,et al.  OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[34]  Jason S. Lewis,et al.  Dosimetry of 60/61/62/64Cu-ATSM: a hypoxia imaging agent for PET , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[35]  G. Thompson,et al.  Anaplastic thyroid carcinoma: a 50-year experience at a single institution. , 2001, Surgery.

[36]  T. Buettner,et al.  Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[37]  A. Hart,et al.  Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial , 2000, The Lancet.

[38]  J. Lewis,et al.  Copper radionuclides and radiopharmaceuticals in nuclear medicine. , 1996, Nuclear medicine and biology.

[39]  T. Wheldon,et al.  Targeted radiotherapy using Auger electron emitters. , 1996, Physics in medicine and biology.

[40]  Y. Yonekura,et al.  Basic characterization of 64Cu-ATSM as a radiotherapy agent. , 2005, Nuclear medicine and biology.